Congo, Democratic Republic of the vs Niger: The number of people with susceptibility test result for rifampicin
Congo, Democratic Republic of the
22.3
in 2021
Niger
11.2
in 2021
Congo, Democratic Republic of the rank
136th
Niger rank
138th
The number of people with susceptibility test result for rifampicin over time
- Congo, Democratic Republic of the
- Niger
How they compare
Congo, Democratic Republic of the currently reports 22.3 against 11.2 in Niger, a difference of 11.1.
That makes Congo, Democratic Republic of the's figure about 2.0 times Niger's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Congo, Democratic Republic of the ahead.
Congo, Democratic Republic of the ranks 136th and Niger ranks 138th of 146 countries.
Congo, Democratic Republic of the has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.66 | 1.85 | 2.81 | Congo, Democratic Republic of the |
| 2020s | 15.68 | 10.1 | 5.57 | Congo, Democratic Republic of the |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Congo, Democratic Republic of the or Niger?
- Congo, Democratic Republic of the, at 22.3 against 11.2 in Niger as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Congo, Democratic Republic of the and Niger?
- 11.1, with Congo, Democratic Republic of the ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Niger?
- 5 years are reported by both, from 2017 to 2021.
- How do Congo, Democratic Republic of the and Niger rank globally for the number of people with susceptibility test result for rifampicin?
- Congo, Democratic Republic of the ranks 136th and Niger ranks 138th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.